Trials / Terminated
TerminatedNCT00905437
Study To Investigate The Effectiveness Of Pregabalin For Management Of Patients Undergoing Total Hip Replacement
Randomized Double-Blind, Multi-Center Study Of Efficacy And Tolerability Of Pregabalin Versus Placebo As An Adjunct To Standard Of Care For Perioperative Management Of Patients Undergoing Total Hip Arthroplasty
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 72 (actual)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is the investigate if pregabalin started a day before surgery and continued for 14 days post-operatively can reduce post-operative pain, relieve pre- and post-operative anxiety and sleep disturbances.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | Placebo as an adjunct to standard of care |
| DRUG | Pregabalin | 75 mg BD for 14 days |
Timeline
- Start date
- 2009-11-01
- Primary completion
- 2012-07-01
- Completion
- 2012-07-01
- First posted
- 2009-05-20
- Last updated
- 2021-01-28
- Results posted
- 2013-06-11
Locations
7 sites across 1 country: India
Source: ClinicalTrials.gov record NCT00905437. Inclusion in this directory is not an endorsement.